- Home
- Publications
- Publication Search
- Publication Details
Title
Getting to HBV cure: The promising paths forward
Authors
Keywords
-
Journal
HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-06
DOI
10.1002/hep.32314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection
- (2021) Nina Hensel et al. NATURE IMMUNOLOGY
- Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
- (2021) Kimberly Page et al. NEW ENGLAND JOURNAL OF MEDICINE
- Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1
- (2021) Jang-June Park et al. Nature Communications
- The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analog therapy
- (2021) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Mechanism of Hepatitis B Virus cccDNA Formation
- (2021) Lei Wei et al. Viruses-Basel
- Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
- (2021) Man-Fung Yuen et al. NATURE MEDICINE
- Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B
- (2020) Mina S Farag et al. CLINICAL INFECTIOUS DISEASES
- Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
- (2020) Michel Bazinet et al. GASTROENTEROLOGY
- Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis
- (2020) Ryan T. Anderson et al. Clinical Gastroenterology and Hepatology
- Effects of Hepatitis B Surface Antigen on Virus-specific and Global T Cells in Patients With Chronic HBV infection
- (2020) Nina Le Bert et al. GASTROENTEROLOGY
- Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
- (2020) Stephane Daffis et al. HEPATOLOGY
- Circulating Pregenomic HBV RNA is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
- (2020) Mark Anderson et al. CLINICAL INFECTIOUS DISEASES
- Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
- (2020) Wai-Kay Seto et al. GUT
- Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection
- (2020) Valeria Fumagalli et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
- (2020) Yu-Chan Yang et al. Molecular Therapy-Nucleic Acids
- Ultra long-term follow-up of interferon-alpha treatment for HBeAg-positive chronic hepatitis B virus infection
- (2020) Hannah S.J. Choi et al. Clinical Gastroenterology and Hepatology
- NUCLEIC ACID POLYMER THERAPY FOR HBV – STRONG HBSAG DECLINE BUT MANY UNANSWERED QUESTIONS
- (2020) Milan J. Sonneveld et al. GASTROENTEROLOGY
- Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen supression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment
- (2020) Edward Gane et al. JOURNAL OF HEPATOLOGY
- Liver toxicity in the Phase 2 Catalyst 206 trial of Inarigivir 400 mg daily added to a nucleoside in HBV EAg negative patients
- (2020) Kosh Agarwal et al. JOURNAL OF HEPATOLOGY
- Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study
- (2020) Man-Fung Yuen et al. JOURNAL OF HEPATOLOGY
- Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection
- (2020) Scott Fung et al. JOURNAL OF HEPATOLOGY
- Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
- (2020) Edward Gane et al. JOURNAL OF HEPATOLOGY
- Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial
- (2020) Florian van Bömmel et al. JOURNAL OF HEPATOLOGY
- Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
- (2020) Stylianos Bournazos et al. NATURE
- Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
- (2020) Ashwin Balagopal et al. JCI Insight
- Therapeutic potential of TLR8 agonist GS‐9688 (selgantolimod) in chronic hepatitis B: re‐modelling of antiviral and regulatory mediators
- (2020) Oliver E. Amin et al. HEPATOLOGY
- Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
- (2020) Mireia García-López et al. JOURNAL OF HEPATOLOGY
- Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load
- (2019) Anita Schuch et al. GUT
- Combined GS-4774 and Tenofovir Therapy can Improve HBV-Specific T-Cell Responses in Patients with Chronic Hepatitis
- (2019) Carolina Boni et al. GASTROENTEROLOGY
- Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
- (2019) Xieer Liang et al. Hepatology International
- Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients
- (2019) Alessandro Loglio et al. JOURNAL OF HEPATOLOGY
- Anti-PD-1 Blockade with Nivolumab with and without Therapeutic Vaccination for Virally Suppressed Chronic Hepatitis B: A Pilot Study
- (2019) Edward Gane et al. JOURNAL OF HEPATOLOGY
- Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade
- (2019) Rohit R. Jadhav et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection
- (2019) Anna D. Kosinska et al. Scientific Reports
- High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
- (2019) Tai-Chung Tseng et al. GASTROENTEROLOGY
- Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
- (2019) Kin Seng Liem et al. GUT
- Pre‐genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy
- (2019) Ivana Carey et al. HEPATOLOGY
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
- (2019) Markus Cornberg et al. JOURNAL OF HEPATOLOGY
- Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
- (2018) S. Van Hees et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Novel potent capsid assembly modulators regulate multiple steps of the Hepatitis B virus life-cycle
- (2018) Thomas Lahlali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
- (2018) Carolina Boni et al. GASTROENTEROLOGY
- Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
- (2018) Wen-Juei Jeng et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
- (2018) Laura Rivino et al. JOURNAL OF CLINICAL INVESTIGATION
- Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients
- (2018) Jing Wang et al. JOURNAL OF HEPATOLOGY
- Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
- (2018) Harry L.A. Janssen et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
- (2018) Franziska Rinker et al. JOURNAL OF HEPATOLOGY
- Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines
- (2018) Suzanne Faure-Dupuy et al. Journal of Innate Immunity
- Natural history of serum HBV-RNA in chronic HBV infection
- (2018) J. Wang et al. JOURNAL OF VIRAL HEPATITIS
- PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
- (2018) Loghman Salimzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating and intrahepatic antiviral B cells are defective in hepatitis B
- (2018) Alice R. Burton et al. JOURNAL OF CLINICAL INVESTIGATION
- Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
- (2018) Yee Hui Yeo et al. GASTROENTEROLOGY
- Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
- (2018) Ruben C Hoogeveen et al. GUT
- The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation among Asian Chronic Hepatitis B Patients: A Systematic Review
- (2018) Jiaye Liu et al. HEPATOLOGY
- Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
- (2018) Barbara Testoni et al. JOURNAL OF HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
- (2017) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)
- (2017) Heng Chi et al. JOURNAL OF INFECTIOUS DISEASES
- Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
- (2017) Paola Fisicaro et al. NATURE MEDICINE
- Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks
- (2017) Manasa Suresh et al. PLoS One
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
- (2017) Christine I. Wooddell et al. Science Translational Medicine
- Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients
- (2017) C.-H. Chen et al. CLINICAL MICROBIOLOGY AND INFECTION
- HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
- (2016) William S. Mason et al. GASTROENTEROLOGY
- Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis
- (2016) Yuchen Xia et al. GASTROENTEROLOGY
- Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
- (2016) Patrick Marcellin et al. GASTROENTEROLOGY
- Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination
- (2016) Danming Zhu et al. JOURNAL OF IMMUNOLOGY
- Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host
- (2016) Anna Schurich et al. Cell Reports
- Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study
- (2015) J. Ahn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
- (2015) T.-C. Tseng et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
- (2015) Seiichi Sato et al. IMMUNITY
- The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
- (2015) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
- (2015) Stephan Menne et al. JOURNAL OF HEPATOLOGY
- AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B
- (2015) Daniela Paulsen et al. PLoS One
- Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
- (2014) W.-K. Seto et al. CLINICAL MICROBIOLOGY AND INFECTION
- Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
- (2014) Stephan Urban et al. GASTROENTEROLOGY
- Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
- (2014) Josh Crouse et al. IMMUNITY
- Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
- (2014) Bertram Bengsch et al. JOURNAL OF HEPATOLOGY
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
- (2014) L. Swadling et al. Science Translational Medicine
- Toll-Like Receptor 8 Agonist and Bacteria Trigger Potent Activation of Innate Immune Cells in Human Liver
- (2014) Juandy Jo et al. PLoS Pathogens
- Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
- (2014) Jia Liu et al. PLoS Pathogens
- Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials
- (2013) Stefania Capone et al. Expert Review of Vaccines
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels
- (2013) Milan J. Sonneveld et al. HEPATOLOGY
- Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
- (2013) Wai-Kay Seto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
- (2013) Dao-Zhen Xu et al. JOURNAL OF HEPATOLOGY
- T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
- (2013) Daniel T Utzschneider et al. NATURE IMMUNOLOGY
- Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection
- (2013) Li-Rung Huang et al. NATURE IMMUNOLOGY
- The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
- (2013) Anna Schurich et al. PLoS Pathogens
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
- (2012) Carolina Boni et al. GASTROENTEROLOGY
- IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
- (2012) Laura Belloni et al. JOURNAL OF CLINICAL INVESTIGATION
- The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication
- (2011) Gaëtan Billioud et al. ANTIVIRAL RESEARCH
- Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
- (2011) Roeland Zoutendijk et al. JOURNAL OF INFECTIOUS DISEASES
- Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B
- (2011) Zeng Minde et al. LIVER INTERNATIONAL
- Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-Up Study
- (2010) Jessica Liu et al. GASTROENTEROLOGY
- Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
- (2010) Alexander J.V. Thompson et al. HEPATOLOGY
- Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
- (2010) Jerzy Jaroszewicz et al. JOURNAL OF HEPATOLOGY
- Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAs
- (2010) Thomas J Cradick et al. MOLECULAR THERAPY
- Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
- (2009) Erik H.C.J. Buster et al. GASTROENTEROLOGY
- Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
- (2009) Paola Fisicaro et al. GASTROENTEROLOGY
- CD8 + T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions
- (2009) Sandra Phillips et al. JOURNAL OF IMMUNOLOGY
- The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection
- (2009) S. Asabe et al. JOURNAL OF VIROLOGY
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started